Because (bio-)medical research very rarely challenges hegemonic power.
-
-
-
It might be because "biomedical" to Trump is economical (see "private-public collaborations"). Shudder to think what they're cooking up.
-
Yeah, dodgey insurance companies MAY be able to collect genetic screening for pre-existing conditions.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.